- ►diabetesjournals.org AJM Boulton, RA Malik, JC Arezzo, JM Sosenko - Diabetes Care, 2004 - Am Diabetes Assoc The neuropathies are among the most common of the long-term complications of diabetes, affecting up
to 50% of patients (1–4). Their clinical features vary immensely, and patients may present to a
wide spectrum of specialties, from ... Cited by 226 - Related articles - BL Direct - All 6 versions
D Ziegler, H Nowak, P Kempler, P Vargha, PA Low - Diabetic Medicine, 2004 - ecopharm.bg Page 1. Treatment of symptomatic diabetic polyneuropathy with the antioxidant a-lipoic acid: A
meta-analysis D. Ziegler1, H. Nowak2, and PA Low3 1German Diabetes Research Institute at the Heinrich
Heine University, Düsseldorf, Germany 2Department of Biostatistics, VIATRIS GmbH, Frankfurt, Germany ... Cited by 179 - Related articles - View as HTML - BL Direct - All 10 versions
- ►endojournals.org AM Vincent, JW Russell, P Low, EL Feldman - Endocrine reviews, 2004 - Endocrine Soc Oxidative stress results from a cell or tissue failing to detoxify the free radicals that are
produced during metabolic activity. Diabetes is characterized by chronic hyperglycemia that produces
dysregulation of cellular ... Cited by 139 - Related articles - BL Direct - All 6 versions
- ►nih.gov A Bierhaus, KM Haslbeck, PM Humpert, B … - Journal of Clinical …, 2004 - Am Soc Clin Investig 1 Departments of Medicine I and Neurology, University of Heidelberg, Heidelberg, Germany. 2
Department of Neurology, University of Erlangen–Nürnberg, Erlangen, Germany. 3 Deutsches
Krebsforschungszentrum, Heidelberg, ... Cited by 98 - Related articles - All 7 versions
- ►diabetesjournals.org D Ziegler, A Ametov, A Barinov, PJ Dyck, I Gurieva, … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this multicenter, randomized, double-blind, placebo-controlled
trial, 181 diabetic patients in Russia and Israel received once-daily oral doses of 600 mg (n = 45)
(ALA600), 1,200 mg (n = 47) ... Cited by 99 - Related articles - BL Direct - All 6 versions
JS Johansen, AK Harris, DJ Rychly, A Ergul - Cardiovascular diabetology, 2005 - cardiab.com Cardiovascular complications, characterized by endothelial dysfunction and accelerated
atherosclerosis, are the leading cause of morbidity and mortality associated with diabetes. There is
growing evidence that excess ... Cited by 88 - Related articles - Cached - All 10 versions
MA Gertz, R Comenzo, RH Falk, JP Fermand, BP … - American Journal of …, 2005 - evasyst.com We undertook this study to develop uniformly accepted criteria for the definition of organ
involvement and response for patients on treatment protocols for immunoglobulin light- chain
amyloidosis (AL). A consensus panel ... Cited by 65 - Related articles - View as HTML - BL Direct - All 9 versions
- ►nih.gov JE Reusch - Journal of Clinical Investigation, 2003 - Am Soc Clin Investig The prevalence of obesity, diabetes, and the metabolic syndrome is increasing in the US and
worldwide at astonishing rates (1, 2). Diabetes is the leading cause of blindness, renal failure,
and amputation in the United ... Cited by 63 - Related articles - BL Direct - All 10 versions
DM Niedowicz, DL Daleke - Cell biochemistry and biophysics, 2005 - Springer The morbidity and mortality associated with diabetes is the result of the myriad complications
related to the disease. One of the most explored hypotheses to explain the onset of complications is
a hyperglycemia-induced increase in ... Cited by 53 - Related articles - BL Direct - All 6 versions
A Grothey - Clinical colorectal cancer, 2005 - CIG Media Group Introduction Oxaliplatin, a third-generation platinum derivative, has be- come an integral part of
the medical treatment of colorectal cancer (CRC).1 The activity of oxaliplatin in CRC is of par-
ticular interest, because cisplatin ... Cited by 47 - Related articles - All 3 versions
